Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Epidemiological trends of fungemia in Greece with focus on candidemia during recent financial crisis: a 10-year survey in a tertiary care academic hospital and review of literature.

Siopi M, Tarpatzi A, Kalogeropoulou E, Damianidou S, Vasilakopoulou A, Vourli S, Pournaras S, Meletiadis J.

Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.01516-19. doi: 10.1128/AAC.01516-19. [Epub ahead of print]

PMID:
31871083
2.

Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.

Beredaki MI, Georgiou PC, Siopi M, Kanioura L, Arendrup MC, Mouton JW, Meletiadis J.

J Antimicrob Chemother. 2020 Jan 1;75(1):140-148. doi: 10.1093/jac/dkz425.

PMID:
31665417
3.

Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources.

Tavakoli M, Rivero-Menendez O, Abastabar M, Hedayati MT, Sabino R, Siopi M, Zarrinfar H, Nouripour-Sisakht S, van der Lee H, Valadan R, Meletiadis J, Yazdani Charati J, Seyedmousavi S, Alastruey-Izquierdo A.

Mycoses. 2020 Jan;63(1):78-88. doi: 10.1111/myc.13019. Epub 2019 Nov 3.

PMID:
31609022
4.

Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.

Meletiadis J, Siopi M, Kanioura L, Jørgensen KM, Perlin DS, Mouton JW, Arendrup MC.

J Antimicrob Chemother. 2019 Aug 1;74(8):2247-2254. doi: 10.1093/jac/dkz154.

PMID:
31106352
5.

In Vitro and In Vivo Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatus.

Siopi M, Mouton JW, Pournaras S, Meletiadis J.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02673-18. doi: 10.1128/AAC.02673-18. Print 2019 Jun.

6.

A New Marker of Echinocandin Activity in an In Vitro Pharmacokinetic/Pharmacodynamic Model Correlates with an Animal Model of Aspergillus fumigatus Infection.

Meletiadis J, Siopi M, Tsakris A, Mouton JW, Pournaras S.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02322-17. doi: 10.1128/AAC.02322-17. Print 2018 May.

7.

Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.

Siopi M, Pournaras S, Meletiadis J.

J Clin Microbiol. 2017 Jun;55(6):1714-1719. doi: 10.1128/JCM.00044-17. Epub 2017 Mar 22.

8.

Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin.

Mpakosi A, Siopi M, Falaina V, Siafakas N, Roilides E, Kimouli M, Theodoraki M, Karle P, Meletiadis J.

Med Mycol Case Rep. 2016 Aug 3;12:24-7. doi: 10.1016/j.mmcr.2016.08.002. eCollection 2016 Jun.

9.

Reply to "Agar Bioassays for Antifungals in Combination Therapy".

Siopi M, Meletiadis J.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5626. doi: 10.1128/AAC.00989-16. Print 2016 Sep. No abstract available.

10.
11.

Bioassay for Determining Voriconazole Serum Levels in Patients Receiving Combination Therapy with Echinocandins.

Siopi M, Neroutsos E, Zisaki K, Gamaletsou M, Pirounaki M, Tsirigotis P, Sipsas N, Dokoumetzidis A, Goussetis E, Zerva L, Valsami G, Meletiadis J.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):632-6. doi: 10.1128/AAC.01688-15. Print 2016 Jan.

12.

Evaluation of paper gradient concentration strips for antifungal combination testing of Candida spp.

Siopi M, Siafakas N, Zerva L, Meletiadis J.

Mycoses. 2015 Nov;58(11):679-87. doi: 10.1111/myc.12413. Epub 2015 Oct 1.

PMID:
26423198
13.

Evaluation of the "Dip Effect" Phenomenon in Antifungal Susceptibility Testing of Candida spp. against Echinocandins by Use of Gradient Concentration Strips.

Siopi M, Tsala M, Siafakas N, Zerva L, Meletiadis J.

J Clin Microbiol. 2015 Nov;53(11):3654-9. doi: 10.1128/JCM.02073-15. Epub 2015 Sep 2.

14.

Optimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model.

Siopi M, Siafakas N, Vourli S, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2015 Jul;59(7):3973-83. doi: 10.1128/AAC.05035-14. Epub 2015 Apr 20.

15.

Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model--authors' response.

Siopi M, Mavridou E, Mouton JW, Verweij PE, Zerva L, Meletiadis J.

J Antimicrob Chemother. 2015 Feb;70(2):634-5. doi: 10.1093/jac/dku484. Epub 2014 Dec 8. No abstract available.

PMID:
25488075
16.

Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model.

Siopi M, Mavridou E, Mouton JW, Verweij PE, Zerva L, Meletiadis J.

J Antimicrob Chemother. 2014 Jun;69(6):1611-9. doi: 10.1093/jac/dku023. Epub 2014 Feb 17.

PMID:
24550381
17.

Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.

Al-Saigh R, Siopi M, Siafakas N, Velegraki A, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2013 Aug;57(8):3713-8. doi: 10.1128/AAC.02484-12. Epub 2013 May 28.

Supplemental Content

Support Center